MX2015007518A - Metodos para tratar el prurito. - Google Patents
Metodos para tratar el prurito.Info
- Publication number
- MX2015007518A MX2015007518A MX2015007518A MX2015007518A MX2015007518A MX 2015007518 A MX2015007518 A MX 2015007518A MX 2015007518 A MX2015007518 A MX 2015007518A MX 2015007518 A MX2015007518 A MX 2015007518A MX 2015007518 A MX2015007518 A MX 2015007518A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- treating pruritus
- pruritus
- treating
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pregnancy & Childbirth (AREA)
- Obesity (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261737488P | 2012-12-14 | 2012-12-14 | |
| US13/715,625 US8637538B1 (en) | 2012-12-14 | 2012-12-14 | Methods for treatment of pruritis |
| PCT/US2013/075096 WO2014093871A1 (en) | 2012-12-14 | 2013-12-13 | Methods for treating pruritus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015007518A true MX2015007518A (es) | 2016-03-01 |
Family
ID=50935003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015007518A MX2015007518A (es) | 2012-12-14 | 2013-12-13 | Metodos para tratar el prurito. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP2931279B1 (enExample) |
| JP (4) | JP2016506398A (enExample) |
| KR (3) | KR20210050585A (enExample) |
| CN (2) | CN110585209A (enExample) |
| AU (2) | AU2013359017B2 (enExample) |
| BR (1) | BR112015013984A2 (enExample) |
| CA (1) | CA2892393C (enExample) |
| ES (1) | ES2984559T3 (enExample) |
| MX (1) | MX2015007518A (enExample) |
| NZ (1) | NZ708371A (enExample) |
| RU (1) | RU2015128265A (enExample) |
| WO (1) | WO2014093871A1 (enExample) |
| ZA (2) | ZA201504229B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI433674B (zh) | 2006-12-28 | 2014-04-11 | Infinity Discovery Inc | 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類 |
| US20140179727A1 (en) | 2012-12-14 | 2014-06-26 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
| RU2015128265A (ru) * | 2012-12-14 | 2017-01-25 | Треви Терапьютикс, Инк. | Способы лечения зуда |
| EP3154546A4 (en) * | 2014-06-13 | 2018-01-10 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
| JP6796638B2 (ja) | 2015-06-04 | 2020-12-09 | ペレファーム, インク.Pellepharm, Inc. | ヘッジホッグ阻害性化合物の送達のための局所的製剤及びその使用 |
| TW201725041A (zh) * | 2016-01-04 | 2017-07-16 | 懷特生技新藥股份有限公司 | 治療皮膚癢之醫藥組合物 |
| CN105560202B (zh) * | 2016-03-11 | 2019-05-24 | 广州玻思韬控释药业有限公司 | 一种盐酸纳布啡凝胶骨架缓释片的制备方法及应用 |
| JP2019509309A (ja) * | 2016-03-21 | 2019-04-04 | トレビ セラピューティクス インコーポレイテッド | 尿毒症性掻痒の治療法 |
| CA3038544A1 (en) * | 2016-10-25 | 2018-05-03 | Trevi Therapeutics, Inc. | Treatment of prurigo nodularis |
| JP7096593B2 (ja) * | 2017-02-03 | 2022-07-06 | 株式会社東洋新薬 | 固形製剤 |
| US20200022974A1 (en) * | 2018-07-23 | 2020-01-23 | Trevi Therapeutics, Inc. | Treatment of chronic cough, breathlessness and dyspnea |
| KR20220127849A (ko) | 2020-01-10 | 2022-09-20 | 트레비 테라퓨틱스, 인코포레이티드 | 날부핀의 투여 방법 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69732868T2 (de) * | 1996-11-25 | 2006-04-13 | Toray Industries, Inc. | Mittel gegen Juckreiz |
| US20030054030A1 (en) * | 2001-09-13 | 2003-03-20 | Gary Gordon | Method and compositions for the treatment of pruritus |
| US6703398B2 (en) * | 2001-11-26 | 2004-03-09 | Oliver Yoa-Pu Hu | Orally administered analgesic compositions containing nalbuphine |
| EP2316429A1 (en) * | 2002-04-05 | 2011-05-04 | Euro-Celtique S.A. | Matrix for sustained, invariant and independent release of active compounds |
| WO2005117871A2 (en) * | 2004-06-03 | 2005-12-15 | Burbaum Jonathan J | Pharmaceutical compositions for the treatment of pruritus |
| PL2402005T3 (pl) * | 2005-08-24 | 2021-11-22 | Endo Pharmaceuticals Inc. | Formulacje nalbufiny o przedłużonym uwalnianiu |
| US8394812B2 (en) * | 2005-08-24 | 2013-03-12 | Penwest Pharmaceuticals Co. | Sustained release formulations of nalbuphine |
| FR2963889B1 (fr) * | 2010-08-20 | 2013-04-12 | Debregeas Et Associes Pharma | Formulations a base de nalbuphine et leurs utilisations |
| RU2015128265A (ru) * | 2012-12-14 | 2017-01-25 | Треви Терапьютикс, Инк. | Способы лечения зуда |
-
2013
- 2013-12-13 RU RU2015128265A patent/RU2015128265A/ru not_active Application Discontinuation
- 2013-12-13 NZ NZ708371A patent/NZ708371A/en unknown
- 2013-12-13 EP EP13863494.4A patent/EP2931279B1/en active Active
- 2013-12-13 AU AU2013359017A patent/AU2013359017B2/en active Active
- 2013-12-13 KR KR1020217012252A patent/KR20210050585A/ko not_active Ceased
- 2013-12-13 WO PCT/US2013/075096 patent/WO2014093871A1/en not_active Ceased
- 2013-12-13 CN CN201910603708.9A patent/CN110585209A/zh active Pending
- 2013-12-13 ES ES13863494T patent/ES2984559T3/es active Active
- 2013-12-13 KR KR1020227010137A patent/KR20220044385A/ko not_active Ceased
- 2013-12-13 KR KR1020157015561A patent/KR20150093702A/ko not_active Ceased
- 2013-12-13 CN CN201380072542.3A patent/CN104981246A/zh active Pending
- 2013-12-13 BR BR112015013984A patent/BR112015013984A2/pt not_active Application Discontinuation
- 2013-12-13 JP JP2015548006A patent/JP2016506398A/ja active Pending
- 2013-12-13 MX MX2015007518A patent/MX2015007518A/es unknown
- 2013-12-13 CA CA2892393A patent/CA2892393C/en active Active
-
2015
- 2015-06-11 ZA ZA2015/04229A patent/ZA201504229B/en unknown
-
2018
- 2018-08-09 AU AU2018214098A patent/AU2018214098B2/en active Active
-
2019
- 2019-04-04 JP JP2019071738A patent/JP6823857B2/ja active Active
- 2019-09-26 ZA ZA2019/06339A patent/ZA201906339B/en unknown
-
2020
- 2020-10-27 JP JP2020179395A patent/JP7072280B2/ja active Active
-
2022
- 2022-04-27 JP JP2022072885A patent/JP2022105095A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NZ708371A (en) | 2020-05-29 |
| ZA201906339B (en) | 2021-07-28 |
| EP2931279A1 (en) | 2015-10-21 |
| ES2984559T3 (es) | 2024-10-29 |
| CA2892393C (en) | 2021-06-08 |
| CA2892393A1 (en) | 2014-06-19 |
| JP2021020947A (ja) | 2021-02-18 |
| AU2018214098B2 (en) | 2019-04-18 |
| HK1215541A1 (en) | 2016-09-02 |
| AU2013359017B2 (en) | 2018-05-10 |
| JP6823857B2 (ja) | 2021-02-03 |
| RU2015128265A (ru) | 2017-01-25 |
| JP2019131588A (ja) | 2019-08-08 |
| JP7072280B2 (ja) | 2022-05-20 |
| BR112015013984A2 (pt) | 2017-07-11 |
| CN104981246A (zh) | 2015-10-14 |
| EP2931279A4 (en) | 2016-05-11 |
| AU2013359017A1 (en) | 2015-06-11 |
| JP2016506398A (ja) | 2016-03-03 |
| KR20150093702A (ko) | 2015-08-18 |
| ZA201504229B (en) | 2021-07-28 |
| WO2014093871A1 (en) | 2014-06-19 |
| AU2018214098A1 (en) | 2018-08-30 |
| JP2022105095A (ja) | 2022-07-12 |
| KR20210050585A (ko) | 2021-05-07 |
| EP2931279B1 (en) | 2024-03-20 |
| CN110585209A (zh) | 2019-12-20 |
| KR20220044385A (ko) | 2022-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015007518A (es) | Metodos para tratar el prurito. | |
| MX2015012401A (es) | Composiciones y metodos de alterar niveles de colesterol. | |
| SG11201506944WA (en) | Betaine compounds as additives for fuels | |
| MX2015002487A (es) | Proceso para la preparacion de teneligliptina. | |
| IN2013DE00266A (enExample) | ||
| IN2014DN08777A (enExample) | ||
| SG11201509341VA (en) | Fuel additive composition | |
| EP2994542A4 (en) | Compositions for ovarian cancer assessment having improved specificity | |
| IN2013MU01113A (enExample) | ||
| IN2014CH00151A (enExample) | ||
| PH12016501183A1 (en) | Novel compound for treatment of severe hypoglycemia | |
| UA117567C2 (uk) | Композиція, яка стимулює лактацію, на основі фосфатидилсерину | |
| IN2015DN00725A (enExample) | ||
| IN2014DN10209A (enExample) | ||
| PH12016501182A1 (en) | Novel compound for treatment of severe hypoglycemia | |
| PH12016501184A1 (en) | Novel compound for treatment of severe hypoglycemia | |
| GB201322176D0 (en) | Fuel additive composition | |
| MX2013002111A (es) | Metodos y composiciones para el tratamiento de metastasis del cancer. | |
| IN2013MU03768A (enExample) | ||
| MY171860A (en) | Method for purifying a crude pnpnh compound | |
| GB201222425D0 (en) | Fuel additive composition | |
| IN2015DN01285A (enExample) | ||
| IN2015KN00386A (enExample) | ||
| UA80618U (en) | Use of n-steroylethanolamine as radiomodifier | |
| UA106373C2 (ru) | Применение поллентара как средства фригопротекторного действия |